| Patents for A61K 9 - Medicinal preparations characterised by special physical form (299,044) |
|---|
| 07/02/2003 | CN1427886A Spray-dried microbial cells |
| 07/02/2003 | CN1427881A Low ionic strength ophthalmic compositions |
| 07/02/2003 | CN1427868A Gel comprised of poly-a-1,4-glucan and starch |
| 07/02/2003 | CN1427765A Method and apparatus for blowmolding capsules of polyvinylalcohol and blowmolded polyvinylalcohol capsules |
| 07/02/2003 | CN1427730A Medicinal aerosol formulation |
| 07/02/2003 | CN1427728A Preparation for evaluating eliminative ability of stomach |
| 07/02/2003 | CN1427727A Gel-like pharmaceutical composition for subcutaneous administration comprising bisphosphonic acids or their salts |
| 07/02/2003 | CN1427723A Composition for treatment of B-type hepatitis and liver cirrhosis |
| 07/02/2003 | CN1427717A Hydrophilic/lipophilic polymeric matrix dosage for mulation |
| 07/02/2003 | CN1427716A Carbohydrate medical solution and sulphite stabilisator in multiple compartment container and use thereof |
| 07/02/2003 | CN1427715A Urogenital or anorectal transmucosal vaccine delivery system |
| 07/02/2003 | CN1427674A Method and apparatus for coating centers |
| 07/02/2003 | CN1426818A Urinary bladder float slow release medicine |
| 07/02/2003 | CN1426816A Veterinarian virus kind biological product heat resisting freeze drying protective agent and its preparation technique |
| 07/02/2003 | CN1426815A Film forming liquid composition |
| 07/02/2003 | CN1426813A Recombination human epidermis growth factor spraying agent and its preparation method |
| 07/02/2003 | CN1426810A Anti alcoholic agent using alder as material and mfg. method thereof |
| 07/02/2003 | CN1426809A Extenal use ointment for restoring period of knocks and falls |
| 07/02/2003 | CN1426801A Preparation method of pain relieving plaster |
| 07/02/2003 | CN1426794A Chinese medicinal plaster for treating hyperosteogeny |
| 07/02/2003 | CN1426788A Chewing gum for preventing sleepy |
| 07/02/2003 | CN1426784A Medicine containing drachonis and its preparation method |
| 07/02/2003 | CN1426780A Gel type slow release tablet for treating diabetes and its preparation method |
| 07/02/2003 | CN1426779A Chinese medicine raw material in form of particles and its preparation method |
| 07/02/2003 | CN1112933C Anti-fungal methods and materials |
| 07/02/2003 | CN1112929C Slow-release pharmaceutical formulations containing mizolastin |
| 07/02/2003 | CN1112927C Pharmaceutical composition of corpus albicans emulsifier type lipophilic compound |
| 07/02/2003 | CN1112924C Rapamycin formulation for TV injection |
| 07/02/2003 | CN1112921C Compositions containing micronized nebivolol |
| 07/02/2003 | CN1112919C Controlled release-initiation and controlled release-rate pharamceutical composition |
| 07/02/2003 | CN1112918C Ophthalmic composition with decreased viscosity |
| 07/02/2003 | CN1112915C New scleroglucans and cosmetic compositions containing new compounds |
| 07/02/2003 | CN1112912C Nose covering material |
| 07/01/2003 | US6586590 Clarified hydrocolloids of undiminished properties and method of producing same |
| 07/01/2003 | US6586574 Lyophilized composition comprising a protein and glycylglycine as a bulking agent; optionally in combination with a sugar, sugar alcohol, and/or an amino acid |
| 07/01/2003 | US6586573 Comprising a bulking agent, stabilizing agents, sodium chloride and a buffering agent; decreased risk of transmitting a virus; used in treating hemophilia |
| 07/01/2003 | US6586559 Polyamide oligomers |
| 07/01/2003 | US6586478 Methods and compositions for improving sleep |
| 07/01/2003 | US6586473 Topical drug delivery composition and method |
| 07/01/2003 | US6586449 Nicotine-containing, controlled release composition and method |
| 07/01/2003 | US6586444 Medicinal compositions |
| 07/01/2003 | US6586440 Uracil substituted at 5-position by C2-4 alkynyl used as inactivator of uracil reductase enzyme |
| 07/01/2003 | US6586438 Low dose combination of metformin and another antidiabetic agent such as glyburide; side effect reduction; for first line therapy in treating diabetes |
| 07/01/2003 | US6586410 Lipid-nucleic acid particles prepared via a hydrophobic lipid-nucleic acid complex intermediate and use for gene transfer |
| 07/01/2003 | US6586409 Adjuvant compositions and methods for enhancing immune responses to polynucleotide-based vaccines |
| 07/01/2003 | US6586407 Injectable pharmaceutical formulations for partricin derivatives |
| 07/01/2003 | US6586404 Pharmaceutical preparations of glutathione and methods of administration thereof |
| 07/01/2003 | US6586040 In the form of plasters for application to the skin to which at least two compositions, each of which is liquid under the processing conditions, are applied as individual layers, one on top of the other |
| 07/01/2003 | US6586023 Active ingredient added to the chewing gum has been treated to control its rate of release from chewing gum by adding the treated active agent to a gum coating |
| 07/01/2003 | US6586015 Use of Phyllanthus for treating chronic inflammatory and fibrotic processes |
| 07/01/2003 | US6586012 To mask the unpleasant taste of pharmaceuticals or nutritional supplements |
| 07/01/2003 | US6586011 For therapy of thrombotic condition and reducing the time required for reperfusion of an occluded blood vessel |
| 07/01/2003 | US6586010 Method for producing agglomerates comprising a core-shell structure |
| 07/01/2003 | US6586008 For delivery to the pulmonary system; particles consist of a therapeutic, prophylactic or diagnostic agent, or any combination thereof, an amino acid or salt thereof, and a phospholipid or combination of phospholipids |
| 07/01/2003 | US6586006 Vitreous vehicle loaded with guest substance such as drugs, enzymes, vaccines; vehicle allows guest substance to be dried and stored without loss of activity |
| 07/01/2003 | US6586005 Extended release formulation of etodolac |
| 07/01/2003 | US6586004 Drug such as lansoprazole, voglibose, or candesartan cilexetil, water soluble sugar alcohol, and low-substituted hydroxypropyl cellulose; tablet with improved buccal disintegration or dissolution |
| 07/01/2003 | US6586003 Emulsion and micellar formulations for the delivery of biologically active substances to cells |
| 07/01/2003 | US6586002 Enhanced circulation effector composition and method |
| 07/01/2003 | US6586001 Neutral lipopolymer and liposomal compositions containing same |
| 07/01/2003 | US6586000 Hydroxide-releasing agents as skin permeation enhancers |
| 07/01/2003 | US6585998 Nutraceutical composition |
| 07/01/2003 | US6585997 Mucoadhesive erodible drug delivery device for controlled administration of pharmaceuticals and other active compounds |
| 07/01/2003 | US6585996 Preferably tetrahydrofurfuryl disulfide; administration methods may include suppository forms, transdermal carriers, such as gels, lotions, or creams; and oral carriers, such as tablets or capsules |
| 07/01/2003 | US6585995 Administering to a subject to inhibit a vaso-occlusive event an agent that reduces platelet counts in the subject in an amount effective to reduce platelet count in the subject to at least a low normal level |
| 07/01/2003 | US6585993 Controlled release neurotoxin system |
| 07/01/2003 | US6585983 Pickering emulsion comprising an oil phase; an aqueous phase, microfine particles, said microfine particles: having both hydrophilic and lipophilic properties resulting in amphiphilic character |
| 07/01/2003 | US6585971 Recombinant α-L-iduronidase, methods for producing and purifying the same and methods for treating disease caused by deficiencies thereof |
| 07/01/2003 | US6585967 Adhesive treatment for tinea cruris |
| 07/01/2003 | US6585963 Nail compositions and methods of administering same |
| 07/01/2003 | US6585959 Excipient having different particle size distribution are added in alternate layers into a suitable mixing vessel; mixing together using a suitable mixer, wherein a portion of the excipient having the larger particle size is added first |
| 07/01/2003 | US6585958 Medicinal aerosol formulations |
| 07/01/2003 | US6585957 Medicinal aerosol formulation |
| 07/01/2003 | US6585763 Implantable therapeutic device and method |
| 07/01/2003 | US6585678 Booster for therapy of disease with ultrasound and pharmaceutical IDLIQU composition containing the same |
| 07/01/2003 | US6585644 Ambulatory medical apparatus and method using a telemetry system with predefined reception listening periods |
| 07/01/2003 | US6584782 Method for producing particulate goods |
| 07/01/2003 | CA2270088C Estrogen- and progesterone-based pharmaceutical composition |
| 07/01/2003 | CA2161225C Cyclodextrin liposomes encapsulating pharmacologic compounds and methods for their use |
| 07/01/2003 | CA2102126C Polymeric compositions |
| 06/26/2003 | WO2003051979A2 Compositions and methods for high sorption of skin materials and delivery of sulfur |
| 06/26/2003 | WO2003051501A1 Process and apparatus for combining virgin material and reground material |
| 06/26/2003 | WO2003051454A2 Methods for particle-assisted polynucleotide immunization using a pulsed electric field |
| 06/26/2003 | WO2003051452A1 Drug implant injection device |
| 06/26/2003 | WO2003051398A1 Parenteral composition of paracetamol |
| 06/26/2003 | WO2003051394A2 Calcium phosphate particles as mucosal adjuvants |
| 06/26/2003 | WO2003051390A1 Use of a polypeptide for treatment of pruritus in animals |
| 06/26/2003 | WO2003051385A1 Pharmaceutical formulation comprising cyclosporin and use thereof |
| 06/26/2003 | WO2003051379A1 Outer membrane vesicles from gram negative bacteria and use as a vaccine |
| 06/26/2003 | WO2003051378A2 Pharmaceutical composition for topical treatment of skin disorders and skin wounds |
| 06/26/2003 | WO2003051375A1 Stabilized brivudine topical formulations |
| 06/26/2003 | WO2003051373A1 Liquid bisphosphonate formulations for bone disorders |
| 06/26/2003 | WO2003051367A1 Parental analgesic formulations comprising fentanyl and a cannabinoid receptor agonist |
| 06/26/2003 | WO2003051364A1 Amlopidine bezylate tablets with improved stability |
| 06/26/2003 | WO2003051363A1 Analgesic delivery systems and methods of use |
| 06/26/2003 | WO2003051355A1 Solid compositions containng compounds unstable to oxygen and method for stabilization thereof |
| 06/26/2003 | WO2003051354A1 Method of treatment |
| 06/26/2003 | WO2003051352A1 Aminoalkyl-benzofuran-5-ol compounds for the treatment of glaucoma |
| 06/26/2003 | WO2003051351A1 Ophthalmic rofecoxib suspension for the treatment of ocular pain and inflammation |
| 06/26/2003 | WO2003051343A1 Pulsatile release histamine h2 antagonist dosage forms |